Literature DB >> 26318606

Abnormalities of the Exocrine Pancreas in Type 1 Diabetes.

Martha Campbell-Thompson1, Teresa Rodriguez-Calvo, Manuela Battaglia.   

Abstract

Type 1 diabetes (T1D) is considered a pancreatic beta cell-specific disease that results in absolute insulin deficiency. Nevertheless, clinical studies from 1940 onwards showed that patients with T1D had an abnormal exocrine pancreas due to the presence of subclinical exocrine insufficiency and acinar atrophy. Exocrine abnormalities are an important, and mostly neglected, characteristic associated with T1D. It is however still unclear whether the exocrine dysfunction in T1D is a primary damage caused by the same pathogenic event that led to beta cell destruction or secondary to beta cell loss. In this review, we collect evidence supporting the hypothesis that T1D is a combined endocrine-exocrine disease in which the loss of functional beta cell mass is most clinically apparent.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26318606      PMCID: PMC5072278          DOI: 10.1007/s11892-015-0653-y

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  53 in total

Review 1.  Value of genetic testing in the management of pancreatitis.

Authors:  D C Whitcomb
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

Review 2.  Chronic pancreatitis, a comprehensive review and update. Part I: epidemiology, etiology, risk factors, genetics, pathophysiology, and clinical features.

Authors:  Thiruvengadam Muniraj; Harry R Aslanian; James Farrell; Priya A Jamidar
Journal:  Dis Mon       Date:  2014-12       Impact factor: 3.800

3.  Pathologic anatomy of the pancreas in juvenile diabetes mellitus.

Authors:  W Gepts
Journal:  Diabetes       Date:  1965-10       Impact factor: 9.461

Review 4.  Infectious causes of acute pancreatitis.

Authors:  D M Parenti; W Steinberg; P Kang
Journal:  Pancreas       Date:  1996-11       Impact factor: 3.327

5.  Prevalence of autoantibodies to carbonic anhydrase II and lactoferrin in patients with type 1 diabetes.

Authors:  Enrico di Cesare; Marcello Previti; Fortunato Lombardo; Nicola Mazzù; Antonino di Benedetto; Domenico Cucinotta
Journal:  Ann N Y Acad Sci       Date:  2004-12       Impact factor: 5.691

6.  Exocrine pancreatic function in juvenile-onset diabetes mellitus.

Authors:  B M Frier; J H Saunders; K G Wormsley; I A Bouchier
Journal:  Gut       Date:  1976-09       Impact factor: 23.059

7.  The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom.

Authors:  A K Foulis; C N Liddle; M A Farquharson; J A Richmond; R S Weir
Journal:  Diabetologia       Date:  1986-05       Impact factor: 10.122

8.  Size of pancreas in children and adolescents with type I (insulin-dependent) diabetes.

Authors:  E Altobelli; A Blasetti; A Verrotti; V Di Giandomenico; L Bonomo; F Chiarelli
Journal:  J Clin Ultrasound       Date:  1998-10       Impact factor: 0.910

9.  Determinants of Exocrine Pancreatic Function as Measured by Fecal Elastase-1 Concentrations (FEC) in Patients with Diabetes mellitus.

Authors:  Nils Ewald; A Raspe; C Kaufmann; R G Bretzel; H U Kloer; P D Hardt
Journal:  Eur J Med Res       Date:  2009-03-17       Impact factor: 2.175

10.  Increased complement activation in human type 1 diabetes pancreata.

Authors:  Patrick Rowe; Clive Wasserfall; Byron Croker; Martha Campbell-Thompson; Alberto Pugliese; Mark Atkinson; Desmond Schatz
Journal:  Diabetes Care       Date:  2013-09-16       Impact factor: 19.112

View more
  37 in total

1.  Insulin promotes proliferation and fibrosing responses in activated pancreatic stellate cells.

Authors:  Jiayue Yang; Richard T Waldron; Hsin-Yuan Su; Aune Moro; Hui-Hua Chang; Guido Eibl; Kevin Ferreri; Fouad R Kandeel; Aurelia Lugea; Ling Li; Stephen J Pandol
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-09-08       Impact factor: 4.052

Review 2.  New Evidence of Exocrine Pancreatopathy in Pre-symptomatic and Symptomatic Type 1 Diabetes.

Authors:  Federica Vecchio; Gloria Messina; Anna Giovenzana; Alessandra Petrelli
Journal:  Curr Diab Rep       Date:  2019-08-31       Impact factor: 4.810

3.  Relative Pancreas Volume Is Reduced in First-Degree Relatives of Patients With Type 1 Diabetes.

Authors:  Martha L Campbell-Thompson; Stephanie L Filipp; Joseph R Grajo; Bimota Nambam; Richard Beegle; Erik H Middlebrooks; Matthew J Gurka; Mark A Atkinson; Desmond A Schatz; Michael J Haller
Journal:  Diabetes Care       Date:  2018-12-14       Impact factor: 19.112

4.  An ancestral retroviral protein identified as a therapeutic target in type-1 diabetes.

Authors:  Sandrine Levet; Julie Medina; Julie Joanou; Amandine Demolder; Nelly Queruel; Kevin Réant; Matthieu Normand; Marine Seffals; Julie Dimier; Raphaële Germi; Thomas Piofczyk; Jacques Portoukalian; Jean-Louis Touraine; Hervé Perron
Journal:  JCI Insight       Date:  2017-09-07

5.  Generation of Scaffold-free, Three-dimensional Insulin Expressing Pancreatoids from Mouse Pancreatic Progenitors In Vitro.

Authors:  Marissa A Scavuzzo; Jessica Teaw; Diane Yang; Malgorzata Borowiak
Journal:  J Vis Exp       Date:  2018-06-02       Impact factor: 1.355

Review 6.  Islet-immune interactions in type 1 diabetes: the nexus of beta cell destruction.

Authors:  L Peters; A Posgai; T M Brusko
Journal:  Clin Exp Immunol       Date:  2019-08-14       Impact factor: 4.330

7.  Persistent elevations in circulating INS DNA among subjects with longstanding type 1 diabetes.

Authors:  Anna Neyman; Jennifer Nelson; Sarah A Tersey; Raghavendra G Mirmira; Carmella Evans-Molina; Emily K Sims
Journal:  Diabetes Obes Metab       Date:  2018-08-24       Impact factor: 6.577

8.  High residual C-peptide likely contributes to glycemic control in type 1 diabetes.

Authors:  Michael R Rickels; Carmella Evans-Molina; Henry T Bahnson; Alyssa Ylescupidez; Kristen J Nadeau; Wei Hao; Mark A Clements; Jennifer L Sherr; Richard E Pratley; Tamara S Hannon; Viral N Shah; Kellee M Miller; Carla J Greenbaum
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

9.  Interpreting type 1 diabetes risk with genetics and single-cell epigenomics.

Authors:  Joshua Chiou; Ryan J Geusz; Mei-Lin Okino; Jee Yun Han; Michael Miller; Rebecca Melton; Elisha Beebe; Paola Benaglio; Serina Huang; Katha Korgaonkar; Sandra Heller; Alexander Kleger; Sebastian Preissl; David U Gorkin; Maike Sander; Kyle J Gaulton
Journal:  Nature       Date:  2021-05-19       Impact factor: 49.962

Review 10.  Diabetes mellitus induced by immune checkpoint inhibitors: type 1 diabetes variant or new clinical entity? Review of the literature.

Authors:  V Lo Preiato; S Salvagni; C Ricci; A Ardizzoni; U Pagotto; C Pelusi
Journal:  Rev Endocr Metab Disord       Date:  2021-01-06       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.